tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF
US Market

Neuren Pharmaceuticals Limited (NURPF) Financial Statements

Compare
54 Followers

Neuren Pharmaceuticals Limited Financial Overview

Neuren Pharmaceuticals Limited's market cap is currently $1.63B. The company's EPS TTM is $0.07947236499999999; its P/E ratio is 16.79; Neuren Pharmaceuticals Limited is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueAU$ 213.24MAU$ 231.93MAU$ 14.55MAU$ 3.20MAU$ 717.00K
Gross ProfitAU$ 213.22MAU$ 205.17MAU$ 14.54MAU$ 3.19MAU$ 711.00K
Operating IncomeAU$ 175.55MAU$ 172.49MAU$ -1.60MAU$ -11.43MAU$ -9.53M
EBITDAAU$ 175.57MAU$ 199.26MAU$ -670.00KAU$ -10.98MAU$ -9.90M
Net IncomeAU$ 142.04MAU$ 157.08MAU$ 184.00KAU$ -7.79MAU$ -9.19M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 222.24MAU$ 228.54MAU$ 40.18MAU$ 36.78MAU$ 24.19M
Total AssetsAU$ 409.71MAU$ 247.97MAU$ 43.27MAU$ 40.06MAU$ 24.95M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -3.15MAU$ -17.09MAU$ -40.18MAU$ -36.78MAU$ -24.19M
Total LiabilitiesAU$ 45.80MAU$ 42.76MAU$ 1.68MAU$ 803.00KAU$ 753.00K
Stockholders' EquityAU$ 363.90MAU$ 205.21MAU$ 41.59MAU$ 39.25MAU$ 24.20M
Cash Flow
Free Cash FlowAU$ -11.28MAU$ 184.88MAU$ 3.58MAU$ -9.98MAU$ -8.08M
Operating Cash FlowAU$ -11.27MAU$ 184.93MAU$ 3.60MAU$ -9.97MAU$ -8.08M
Investing Cash FlowAU$ 4.13MAU$ -211.49MAU$ -19.00KAU$ -10.00KAU$ -6.00K
Financing Cash FlowAU$ -8.78MAU$ 3.62MAU$ -2.00KAU$ 22.18MAU$ 19.14M
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

Neuren Pharmaceuticals Limited Debt to Assets

Neuren Pharmaceuticals Limited Cash Flow

Neuren Pharmaceuticals Limited Forecast EPS vs Actual EPS